Distinct Clonal Identities of B-ALLs Arising after Lenolidomide Therapy for Multiple Myeloma

Samples from 17 patients with with multiple myeloma treated with lenalidomide, who subsequently developed B-cell acute lymphoblastic leukemia (B-ALL) were evaluated through sequencing, cytogenetics/fluorescence in situ hybridization, immunohistochemical staining, and immunoglobulin heavy chain clonality assessment.
[Blood Advances]
Full ArticleGraphical Abstract

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News